Green Cross Medical Science Corporation (KOSDAQ:142280)
4,115.00
-55.00 (-1.32%)
At close: Aug 14, 2025, 3:30 PM KST
KOSDAQ:142280 Revenue
Green Cross Medical Science had revenue of 26.48B KRW in the quarter ending March 31, 2025, with 11.75% growth. This brings the company's revenue in the last twelve months to 106.64B, up 13.07% year-over-year. In the year 2024, Green Cross Medical Science had annual revenue of 103.85B with 10.47% growth.
Revenue (ttm)
106.64B
Revenue Growth
+13.07%
P/S Ratio
0.84
Revenue / Employee
874.06M
Employees
122
Market Cap
89.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 103.85B | 9.84B | 10.47% |
Dec 31, 2023 | 94.01B | -19.10B | -16.88% |
Dec 31, 2022 | 113.11B | 11.43B | 11.25% |
Dec 31, 2021 | 101.67B | -11.70B | -10.32% |
Dec 31, 2020 | 113.38B | 31.88B | 39.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hyundai Motor Company | 178.98T |
Hanwha Aerospace | 15.28T |
Doosan Enerbility | 15.88T |
KB Financial Group | 15.69T |